With a formerly unbeaten track record of nine consecutive defense verdicts, Bayer AG’s success concerning litigation over its subsidiary Monsanto’s Roundup suddenly came to a halt when five verdicts resulted in over $2 billion in penalties throughout 2023.
Roundup has been on the receiving end of legal actions due to allegations that its key ingredient glyphosate, a widely used herbicide, is carcinogenic. How did this unexpected turn of events come about in the courtroom, and more importantly, what does this mean for future legal actions involving Monsanto in 2024?
The jury’s shift of perspective and the implications these substantial punitive damages might have for Monsanto moving forward constitute a significant point of interest for legal professionals worldwide. For a detailed discussion of the courtroom dynamics that led to this shift and potential outlook for Monsanto, consider this piece from Law.com.
The path to understanding both the legal and corporate repercussions of these verdicts, and how they may impact Monsanto’s future litigation strategy, commences with comprehensive knowledge of the judicial proceedings at foot and an appreciation of the broader legal landscape.